A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity

NCT06373146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

392

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Tirzepatide
DRUG: Mibavademab
DRUG: Tirzepatide-Placebo
DRUG: Mibavademab-Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]